Thomas C. Chelimsky, MD



  • Froedtert Hospital
  • Children's Wisconsin - Milwaukee
  • Neuroscience Institute – Specialty Clinics
  • Children's Wisconsin Clinics - Milwaukee


  • Neurology


  • English

Currently Not Accepting New Patients - Call for Help Locating a Similar Provider


  • MD - Doctor of Medicine



Autonomic Disorders


1983-86 - Mayo Clinic, Residency, Internal Medicine

1986-89 - Mayo Clinic, Residency, Neurology

1986-87 - Mayo Clinic, Fellowship, Autonomic Research

1989-90 - Mayo Clinic, Electromyography

Memberships in Professional Organizations

American Autonomic Society
American College of Physicians
American Academy of Neurology
American Association of Electrodiagnostic Medicine
International Association for the Study of Pain

Professional Service


External Reviewer, Dutch Ministry of Health Care, Welfare and Sport - The Netherlands Organisation for Health Research and Development (ZonMw). 10/2003

External Reviewer, Austrian Science Fund, Vienna (Fonds zur Förderung der wissenschaftlichen Forschung (FWF) Weyringergasse 35 A 1040 Wien). 2/2004


Independent Medical Monitor for Double-Blind Placebo Controlled Treatment Trial of MSA with Rifampicin. Funded By NINDS. U54 (PI: David Robertson) And P01 (PI, Phillip Low). Sep 2010 – trial completion.

NIH Study Section: Somatosensory and chemosensory systems study section (SCS) 2/2010, San Diego

NIH ARA Challenge Grant Reviewer, 2009

Member and Acting Chair, NIH Study Section Special Emphasis Panel ZRG1 CFS; Chronic Fatigue Syndrome/Fibromyalgia Syndrome 7/2000-2007

Member, NIH (NINDS) Study Section Special Emphasis Panel ZNS1 SRB-A; Autonomic Disorders 2005, 2009.

External reviewer, VA Merit Awards: 2002


(AAN = American Academy of Neurology; AAS = American Autonomic Society)

Secretary/Treasurer, AAS, 2010
Board of Directors, UCNS 2010-2012
Consensus Panel Member, Orthostatic Hypotension Definition, 2010
Co-Chair, AAN autonomic scientific session, April 2010, Toronto
Chair, UCNS autonomic fellowship accreditation committee, 2009
Educational Subcommittee Topic Work Group Member for Neuromuscular, AAN 2008
Chair-elect, AAN Pain Section, 2007-2009
Board of Directors, AAS, 2007-2010
Abstract reviewer, AAN Scientific Session, 2007
Abstract reviewer, AAN, 2010
Co-Chair AAS Scientific Session “Music and the ANS”, 2007 Vienna
Co-Chair AAS Scientific Session, 2006
Chair, AAN Autonomic Section 2004-2007
Vice-Chair, AAN Autonomic Section 2002-2004
Member of Board of Directors, National Multiple System Atrophy Association, 2000
Councilor, AAN Pain Section 2005-2007
Chair, AAN Scientific Session; Autonomic Section, 2000-2001
Abstract Reviewer, AAN Scientific Session; Autonomic Section 2000-2003
Secretary-Treasurer, AAN Autonomic Section 2000-2001
Webmaster, AAN Autonomic Section, 1999-2003


Neurology Faculty Representative, Faculty Council, School of Medicine, Case Western Reserve University, 2007-2011

Interviewer for Medical School Applicants, School of Medicine Admissions Committee, 2005

Member, Tenure and Promotions Committee, Department of Neurology, Case Western Reserve University, 1992-1995; 2003

Director, Extramural teaching and speaker's bureau, Department of Neurology, University Hospitals of Cleveland 1992-1996


Chair, Credentialing Committee, Department of Neurology
University Hospitals of Cleveland, 1992-2007
Chair, Rehabilitation Services Advisory Committee
University Hospitals of Cleveland, 1995-2003
Member, Medical Records Committee
University Hospitals of Cleveland, 1993-2003

Editorial Boards and Referee Duties

Associate Editor: Frontiers in Autonomic Neuroscience 2010-
Ad Hoc Reviewer for Neurology 1989-
Ad Hoc Reviewer for NEJM 2007-
Ad Hoc Reviewer for Annals of Neurology 2002-
Ad Hoc Reviewer for The Journal of Neurosurgery 1991-97
Ad Hoc Reviewer for Mayo Clinic Proceedings 1991-96
Ad Hoc Reviewer for Clinical Autonomic Research 1996-
Ad Hoc Reviewer for Autonomic Neuroscience 1999-
Ad Hoc Reviewer for JPNS 1996-98
Ad Hoc Reviewer for Archives of Neurology 2000-
Ad Hoc Reviewer for JNNP 2002-
Ad Hoc Reviewer for Annals of Family Medicine 2002-
Ad Hoc Reviewer for J Dermatologic Science 2003-
Ad Hoc Reviewer for Diabetes 2003-

View Faculty Collaboration Database profile

Honors and Awards

Scholarship in Teaching Award, Case Medical School 2006 for 4PCP Project
SAGES Presidential Fellow 2004
UH Pain Program CARF 3-year Accreditation 2004: “National Leader”
Best Doctors in America 2001-2011
UH Pain Program CARF 3-year Accreditation 1997: “Model for the Nation”

Research Interests

Past and Present Research Support

CTSC grant from Case Western Reserve University. Electroconvulsive therapy in multiple system atrophy. 6/1/11 to 5/31/12. Thomas Chelimsky PI. $50k over 1 year.

Principle Investigator R01-DK083538 NIH NIDDK Interstitial Cystitis Elucidation of Psychophysiologic and Autonomic Characteristics (ICEPAC). 7/1/09 to 6/30/14. $3,734,188 over 5 years. Co-Investigators: Buffington CAT, Janata, J

Co-PI R13NS073226-01 (NINDS), $15,000 Primary Care Workshop in Autonomic Disorders and Syncope Marco Island, November 2010

Research Mentor, Brain-Heart Institute Award (5% effort); “Central Autonomic Regulation in Complex Regional Pain Syndrome” $150,000; 1/1/09 to 1/1/11. PI Chemali, K

Double-blind placebo-controlled trial of rasagiline as neuroprotective agent in multiple system atrophy. Teva Pharmaceuticals; Sid Gilman study director. 7/1/10 – Study termination.

Principle Investigator Fishbein Family IC Research Foundation (5% effort): "Familial Aggregation of Interstitial Cystitis with Other Functional Autonomic Disorders" $28,668; 10/1/07 to 9/30/08 Co-investigators: Buffington, T; Rackley, R.

Principle Investigator (40% effort) funded by Josiah Macy Jr. Foundation, NY, “A controlled study of an interdisciplinary pain management approach led by primary care physicians” The 4PCP trial (Primary Practice Program for Patients with Chronic Pain). $983,076. 7/1/04 to 6/30/09.

Double-blind placebo-controlled trial of Droxidopa (L-3,4-DOPS) in orthostatic hypotension. Chelsea Pharmaceuticals study investigator (5% effort). 3/1/08 to study termination. H Kaufman study director.

Site Principle Investigator (approx 5% effort), NIH multi-center study, P01 NS44233 “The pathogenesis and diagnosis of multiple system atrophy”; Project P.I. Cliff Shults, MD (UCSD Dept of Neuroscience). 7/1/03 to 6/30/06.

Shire 404 study investigator (approx 3% effort): “A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Crossover Study to Assess the Clinical Benefit of Midodrine Hydrochloride in Subjects with Moderate to Severe Neurogenic Orthostatic Hypotension” (Protocol SPD426.404). 10/1/04 to 4/30/05.

Shire 401 study investigator (approx 5% effort): “A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Crossover Study to Assess the Clinical Benefit of Midodrine Hydrochloride in Subjects with Neurogenic Orthostatic Hypotension” (Protocol 20,762-401). 10/1/03 to 1/15/05.

Roberts Pharmaceutical Corporation (approx 5% effort): Phase 3 Study of Midodrine Hydrochloride in Subjects with Neurogenic Orthostatic Hypotension. 7/1/94 to 6/1/95.

Case Research Development Grant (RIG - $5000): Autonomic Changes in Patients with Arthritic Limb Pain. 7/1/93 to 7/1/94.